The Stock Of The Week: Applied Therapeutics Inc. (APLT)

0
3
BBAI
BBAI

As of Wednesday close, Applied Therapeutics Inc.’s (NASDAQ:APLT) stock was up $0.04, moving up 4.71 percent to $0.89. The average number of shares traded per day over the past five days has been 271,800 shares. 2 times new highs have been achieved over the past 5 days, with a $0.0400 gain in that time frame. In the last twenty days, the average volume was 366,365, while in the previous 50 days, it was 366,128.

Since last month, APLT stock rose 28.06%. Shares of the company fell to $0.6370 on 10/24/22, the lowest level in the past month. A 52-week high of $11.87 was reached on 01/03/22 after having rallying from a 52-week low of $0.50. Since the beginning of this year, APLT’s stock price has dropped by -90.06% or -$8.0600, and marked a new high 1 time. However, the stock has declined by -92.50% since its 52-week high.


China Can't Stop US$0.25 Stock from Mining Ultra-Rare Metal

Here's one little-known company — trading undiscovered below 25-cents per share — that's advancing one of the largest and highest quality REE deposits in all of North America... and the Chinese can't do a damn thing about it! It's early stage... and that's excellent news for individual investors like you who have the foresight to act decisively on an emerging megatrend that's already being measured in the Tens of $Billions.

Simply click here and the name & trading symbol are yours.

Sponsored


APLT stock investors should be aware that Applied Therapeutics Inc. (APLT) stock had its last reported insider trading activity 41 days ago on Oct 14. Shendelman Shoshana, the President and CEO of the company, purchased of 50,000 shares for $0.65 on Oct 14. It resulted in a $32,250 investment by the insider. Shendelman Shoshana added 73,256 shares at an average price of $0.56 on Oct 13. The insider now owns 717,495 shares following the transaction. On Oct 12, President and CEO Shendelman Shoshana bought 38,153 shares at $0.52 apiece. The transaction was valued at $19,943.

Financial Health

In the three months ended June 29, Applied Therapeutics Inc.’s quick ratio stood at 1.20, while its current ratio was 1.20, showing that the company is able to pay off its debt.

While analysts expected Applied Therapeutics Inc. to report -$0.78 quarterly earnings, the actual figure was -$0.96 per share, beating the consensus estimate by -23.10%. The liabilities of Applied Therapeutics Inc. were 47.05 million at the end of its most recent quarter ended June 29, and its total debt was $3.6 million. The value of shareholders’ equity is $48.06 million.

Technical Picture

This quick technical analysis looks at Applied Therapeutics Inc.’s (APLT) price momentum. With a historical volatility rate of 102.83%, the RSI 9-day stood at 62.42% on 23 November.

With respect to its five-day moving average, the current Applied Therapeutics Inc. price is up by +4.71% percent or $0.0400. At present, APLT shares trade +30.86% above its 20-day simple moving average. However, the stock is currently trading approximately -41.06% below its SMA50 and -65.50% below its SMA200.

Stochastic coefficient K was 57.03% and Stochastic coefficient D was 55.27%, while ATR was 0.1029. Given the Stochastic reading of 65.79% for the 14-day period, the RSI (14) reading has been calculated as 57.35%.

Analyst Ratings

Applied Therapeutics Inc. downgraded its rating on Applied Therapeutics Inc. (NASDAQ: APLT) to an Equal weight in a note to investors on January 04, 2022. The analysts firm previously had an Overweight rating on the stock.Applied Therapeutics Inc. (APLT) has been rated Overweight by analysts. According to 0 brokerage firms, APLT is a sell, and 1 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 1 analyst rate Applied Therapeutics Inc. stock as buy, with 2 recommending it as overweight.

With a median target price of $4.00, the current consensus forecast for the stock is $1.00 – $18.00. Based on these forecasts, analysts predict Applied Therapeutics Inc. (APLT) will achieve an average price target of $7.67.

LEAVE A REPLY

Please enter your comment!
Please enter your name here